XML 43 R31.htm IDEA: XBRL DOCUMENT v3.24.3
ASSETS MEASURED AT FAIR VALUE (Tables)
 9 Months Ended
Sep. 30, 2024
Schedule of Investments [Line Items]  
SCHEDULE OF FINANCIAL ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS

Financial assets measured at fair value on a recurring basis are summarized below and disclosed on the condensed consolidated balance sheet as of September 30, 2024 and December 31, 2023:

 

   Fair Value Measurement Using   Amount at 
   Level 1   Level 2   Level 3   Fair Value 
September 30, 2024                    
Assets                    
Investment Securities- Fair Value Option  $13,124,908   $966,175   $-   $14,091,083 
Investment Securities- Trading   4,676,413    1,864,017    -    6,540,430 
Warrants – NECV   -    -    973    973 
Warrants - VEII   -    1,655,829    -    1,655,829 
Warrants - SHRG   -    3,891    -    3,891 
Convertible Loan Receivable - VEII   -    604,221    -    604,221 
Convertible Loan Receivable - SHRG   -    1,007,243    -    1,007,243 
                     
Total Assets at Fair Value  $17,801,321   $6,101,376   $973   $23,903,670 

 

   Fair Value Measurement Using   Amount at 
   Level 1   Level 2   Level 3   Fair Value 
December 31, 2023                    
Assets                    
Investment Securities- Fair Value Option  $7,537,472   $2,100,720   $-   $9,638,192 
Investment Securities- Trading   35,036    1,779,601    -    1,814,637 
Convertible Note Receivable   -    -    77,307    77,307 
Warrants - NECV   -    -    430    430 
Warrants- VEII   -    2,487,854    -    2,487,854 
Convertible Loan Receivable - VEII   -    1,207,627    -    1,207,627 
                     
Total Assets at Fair Value  $7,572,508   $7,575,802   $77,737   $15,226,047 
SCHEDULE OF FAIR VALUE OF EQUITY SECURITY INVESTMENT

    Share price           Market Value      
    9/30/2024     Shares     9/30/2024     Valuation
                       
DSS (Related Party)   $ 1.270       3,140,613     $ 3,988,579     Investment in Securities at Fair Value – Related Party
                             
Impact BioMedical (Related Party)   $ 2.000       4,568,165     $ 9,136,329     Investment in Securities at Fair Value – Related Party
                             
Trading Stocks                   $ 4,676,413     Investment in Securities at Fair Value
                             
      Total Level 1 Equity Securities     $ 17,801,321      
                             
AMBS   $ 0.000       20,000,000     $ 2,000     Investment in Securities at Fair Value
                             
Holista   $ 0.017       1,000     $ 17     Investment in Securities at Fair Value
                             
Value Exchange (Related Party)   $ 0.045       21,179,275     $ 955,185     Investment in Securities at Fair Value – Related Party
                             
New Electric CV (Related Party)   $ 0.000       354,039,000     $ -     Investment in Securities at Fair Value – Related Party
                             
Sharing Services (Related Party)   $ 0.100       89,732  *   $ 8,973     Investment in Securities at Fair Value – Related Party
                             
Trading Stocks                   $ 1,864,017     Investment in Securities at Fair Value
                             
      Total Level 2 Equity Securities     $ 2,830,192      
                             
Nervotec     N/A       1,666     $ 624     Investment in Securities at Cost
UBeauty     N/A       3,600     $ 16,714     Investment in Securities at Cost
Ideal Food and Beverages     N/A       19,000     $ 14,829     Investment in Securities at Cost
HapiTravel Holding     N/A       19,000     $ 148     Investment in Securities at Cost
      Total Equity Securities     $ 20,663,828      

 

 

    Share price           Market Value      
    12/31/2023     Shares     12/31/2023     Valuation
                       
DSS (Related Party)   $ 0.120       62,812,264     $ 7,537,472     Investment in Securities at Fair Value – Related Party
                             
Trading Stocks                   $ 35,036     Investment in Securities at Fair Value
                             
      Total Level 1 Equity Securities     $ 7,572,508      
                             
AMBS   $ 0.001       20,000,000     $ 10,000     Investment in Securities at Fair Value
                             
Holista   $ 0.007       36,159,845     $ 246,556     Investment in Securities at Fair Value
                             
Value Exchange (Related Party)   $ 0.067       21,179,275     $ 1,429,602     Investment in Securities at Fair Value – Related Party
                             
Sharing Services (Related Party)   $ 0.003       125,624,528     $ 414,562     Investment in Securities at Fair Value – Related Party
                             
New Electric CV (Related Party)   $ 0.000       354,039,000     $ -     Investment in Securities at Fair Value – Related Party
                             
Trading Stocks                   $ 1,779,601     Investment in Securities at Fair Value
                             
      Total Level 2 Equity Securities     $ 3,880,321      
                             
Nervotec     N/A       1,666     $ 37,876     Investment in Securities at Cost
UBeauty     N/A       3,600     $ 16,636     Investment in Securities at Cost
      Total Equity Securities     $ 11,507,341      

 

* Ratio of 1-for-1,400 (the “Reverse Split”) was effective on September 13, 2024.
Sharing Services Convertible Note [Member]  
Schedule of Investments [Line Items]  
SCHEDULE OF CHANGE IN FAIR VALUE

The table below provides a summary of the changes in fair value which are recorded as other comprehensive income (loss), including net transfers in and/or out of all financial assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended September 30, 2024 and 2023:

 

   Total 
Balance at January 1, 2024  $77,737 
Impairment   (77,307)
Total Gains   543 
Balance at March 31, 2024  $973 
Total Gains   - 
Balance at June 30, 2024  $973 
Total Gains   - 
Balance at September 30, 2024  $973 

 

 

   Total 
Balance at January 1, 2023  $416,164 
Total Gains   62,348 
Balance at March 31, 2023  $478,512 
Total Losses   (342,798)
Balance at June 30, 2023  $135,714 
Total Losses   (46,685)
Balance at September 30, 2023  $89,029 
NECV Warrants [Member]  
Schedule of Investments [Line Items]  
SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

The fair value of the NECV warrants under level 3 category as of September 30, 2024 and December 31, 2023 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:

 

   September 30, 2024   December 31, 2023 
         
Stock Price  $0.0001   $0.0001 
Exercise price  $0.001   $0.001 
Risk free interest rate   4.62%   4.62%
Annualized volatility   869.4%   869.4%
Dividend Yield  $0.00   $0.00 
Year to maturity   5.81    6.56 
VEII Warrants [Member]  
Schedule of Investments [Line Items]  
SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

The fair value of the VEII warrants under level 2 category as of September 30, 2024, and December 31, 2023 was calculated using a Black-Scholes valuation model valued with the following weighted average assumptions:

 

   September 30, 2024   December 31, 2023 
         
Stock price  $0.0451   $0.0677 
Exercise price  $0.1770   $0.1770 
Risk free interest rate   8.00%   8.50%
Annualized volatility   384.22%   275.85%
Dividend Yield  $0.00   $0.00 
Year to maturity   3.93    4.68 
SHRG Warrants [Member]  
Schedule of Investments [Line Items]  
SCHEDULE OF SIGNIFICANT INPUTS AND ASSUMPTIONS

The fair value of the SHRG warrants under level 2 category as of September 30, 2024, was calculated using binomial option pricing model valued with the following weighted average assumptions:

 

   September 30, 2024 
     
Stock price  $0.0100 
Exercise price  $1.68 
Risk free interest rate   3.56%
Annualized volatility   167.12%
Dividend Yield  $0.00 
Year to maturity   4.46